A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

Overview of attention for article published in Acta Neuropathologica, February 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 23 patents
video: 1 YouTube creator

Citations

dimensions_citation: 392 Dimensions

Readers on

mendeley: 468 Mendeley

So far, Altmetric has seen 23 patents that reference this research output.

A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

About this Attention Score

Mentioned by

Citations

Readers on

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Grant US-11739140-B2

United States of America

Anti-Tau antibodies and uses thereof

Grant US-11578120-B2

United States of America

Agents, uses and methods for the treatment of synucleinopathy

Grant US-11542323-B2

United States of America

Agents, uses and methods for the treatment of synucleinopathy

Grant US-11524995-B2

United States of America

Agents, uses and methods for the treatment of synucleinopathy

Grant US-11421024-B2

United States of America

Alpha-synuclein antibodies

Grant US-11325968-B2

United States of America

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Grant US-11111290-B2

United States of America

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Grant US-10934348-B2

United States of America

Agents, uses and methods for the treatment of synucleinopathy

Grant US-10889635-B2

United States of America

Anti-tau antibodies and uses thereof

Grant US-10829547-B2

United States of America

Agents, uses and methods for the treatment of synucleinopathy

Grant US-10800836-B2

United States of America

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Grant US-10647762-B2

United States of America

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Grant US-10562962-B2

United States of America

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Grant US-10487142-B2

United States of America

Antibodies specific for hyperphosphorylated tau and methods of use

Grant US-10472415-B2

United States of America

Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation

Grant US-10364286-B2

United States of America

Antibodies for the treatment of synucleinopathy

Grant US-10364285-B2

United States of America

Antibodies for the treatment of synucleinopathy

Grant US-10358482-B2

United States of America

Antibodies for the treatment of synucleinopathy

Grant US-10358484-B2

United States of America

Antibodies for the treatment of synucleinopathy

Grant US-10358483-B2

United States of America

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Grant US-10196439-B2

United States of America

METHODS FOR DETECTING NEURODEGENERATIVE PROTEINOPATHIES

Application WO-2016059144-A1

World Intellectual Property Organisation (WIPO)

SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF

Application WO-2015089375-A1

World Intellectual Property Organisation (WIPO)